Rabaca, Sunshin .
HRN: 26-83-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2025
CEFUROXIME 500MG (TAB)
04/17/2025
04/24/2025
ORAL
500mg
BID
S/P NSD With Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes